WO1986004610A1 - Solutions enzymatiques stabilisees comprenant un substrat - Google Patents
Solutions enzymatiques stabilisees comprenant un substrat Download PDFInfo
- Publication number
- WO1986004610A1 WO1986004610A1 PCT/US1986/000229 US8600229W WO8604610A1 WO 1986004610 A1 WO1986004610 A1 WO 1986004610A1 US 8600229 W US8600229 W US 8600229W WO 8604610 A1 WO8604610 A1 WO 8604610A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- solution
- acid
- substrate
- chromogen
- chelating agent
- Prior art date
Links
- 239000000758 substrate Substances 0.000 title claims abstract description 35
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 27
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 27
- 239000002738 chelating agent Substances 0.000 claims abstract description 29
- 238000003556 assay Methods 0.000 claims abstract description 21
- 230000003647 oxidation Effects 0.000 claims abstract description 14
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 14
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- 150000002978 peroxides Chemical class 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 10
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 claims description 8
- 239000000872 buffer Substances 0.000 claims description 8
- 229960003330 pentetic acid Drugs 0.000 claims description 8
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 claims description 6
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 6
- 102000003992 Peroxidases Human genes 0.000 claims description 5
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 claims description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 4
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 3
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical compound C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 claims description 2
- NUBOMXHHTQFVBI-UHFFFAOYSA-N 4-[2-amino-5-[4-amino-3-(3-carboxypropoxy)phenyl]phenoxy]butanoic acid Chemical compound C1=C(OCCCC(O)=O)C(N)=CC=C1C1=CC=C(N)C(OCCCC(O)=O)=C1 NUBOMXHHTQFVBI-UHFFFAOYSA-N 0.000 claims description 2
- SXEHKFHPFVVDIR-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine Chemical compound C1=CC(NN)=CC=C1C1=CC=C(NN)C=C1 SXEHKFHPFVVDIR-UHFFFAOYSA-N 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000004989 dicarbonyl group Chemical group 0.000 claims description 2
- 150000001261 hydroxy acids Chemical class 0.000 claims description 2
- 239000001384 succinic acid Substances 0.000 claims description 2
- 239000003547 immunosorbent Substances 0.000 claims 1
- 238000003018 immunoassay Methods 0.000 abstract description 9
- 238000002965 ELISA Methods 0.000 abstract description 6
- 239000000243 solution Substances 0.000 description 29
- 229940123150 Chelating agent Drugs 0.000 description 22
- 239000012224 working solution Substances 0.000 description 19
- 230000000694 effects Effects 0.000 description 11
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 10
- 239000011550 stock solution Substances 0.000 description 9
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 6
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 102000012406 Carcinoembryonic Antigen Human genes 0.000 description 5
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 102000013415 peroxidase activity proteins Human genes 0.000 description 5
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 4
- 108700020962 Peroxidase Proteins 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 235000013024 sodium fluoride Nutrition 0.000 description 3
- 239000011775 sodium fluoride Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000012062 aqueous buffer Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229940124272 protein stabilizer Drugs 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- HQFLTUZKIRYQSP-UHFFFAOYSA-N 3-ethyl-2h-1,3-benzothiazole-6-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2N(CC)CSC2=C1 HQFLTUZKIRYQSP-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- -1 TMB Chemical compound 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002494 anti-cea effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229910001447 ferric ion Inorganic materials 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
Definitions
- This invention relates to an improved enzyme immunoassay (EIA), enzyme linked immunosorbent assay (ELISA), immunoenzymometric assay or immunoperoxidase assay and pertains most specifically to a substrate solution for determining enzyme activity which contains ethyienediaminetetraacetic acid resulting in increased stability of the substrate solution and decreased substrate drift.
- EIA enzyme immunoassay
- ELISA enzyme linked immunosorbent assay
- immunoenzymometric assay immunoperoxidase assay
- Enzyme immunoassays, enzyme linked immunosorbent assays and immunoenzymometric assays involve the use of an enzyme, such as a peroxidase, as a label for the unknown in an assay procedure, and measurement of the enzyme activity as an indication of the amount of the unknown in the sample.
- Immunoperoxidase assays apply the same principles to microscopic examination of cultures or tissues. Such assays typically require the addition of the substrate for the enzyme after the immunoassay in order to determine the amount of "bound" enzyme.
- Peroxidases, such as horseradish peroxidase require two substrates — a peroxide and a chromogen which affords a colored product upon oxidation. Typically, stock solutions of the peroxide and the chromogen are combined in the appropriate buffer to form a "working" substrate solution.
- the working solution With the usual chromogen, o-phenylenediamine, the working solution is quickly oxidized nonenzymatically resulting in an increase in color development even in the absence of peroxidase. Thus, the working solution must be used within 1/2 hour of preparation.
- TMB 3,3',5,5'-tetramethylbenzidine
- the present invention can be used to determine peroxidase act vity of any enzyme which catalyzes the reaction of the chromogen with peroxide to form a colored compound.
- peroxidases such as horseradish peroxidase
- other peroxidases may also be used.
- “Chelating agent” as used in this invention means any compound in which a dicationic, tricationic or tetracationic metal is bound to two or more atoms or complexes with ligands containing more than one point of attachment.
- Chelating agents which can be used in the present invention include any chelating agent which binds heavy metals preventing nonenzymatic oxidation of the substrate solution without preventing enzymatic oxidation or the formation or detection of color.
- Preferred chelating agents are nontoxic and do not present a biohazard.
- EDTA ethyienediaminetetraacetic acid
- DTPA diethylenetriaminepentaacetic acid
- iminodiacetic acid and other derivatives iminodiacetic acid and other derivatives
- nitrilotriacetic acid and derivatives succinic acid and other diacids
- citric acid and other hydroxyacids and acetylacetone and other dicarbonyl compounds Preferred chelating agents are EDTA and its derivatives, DTPA and its derivatives, iminodiacetic acid and its derivatives, and nitrilotriacetic acid and its derivatives.
- EDTA due to its solubility in the buffer of the stock and working solutions and its ability strongly to chelate a variety of metal ions at the pH of the working solution.
- Chelating agents which are not useful in the present invention are those which actually increase the rate of non-enzymatic oxidation of the chromogen or substrate, such as dip colinic acid. These chelating agents will be obvious to one skilled in the art without undue experimentation.
- the concentration of chelating agent in the working solutions will be dependent upon effective el mination of drift and minimization of interference with the enzymatic oxidation of the substrate. In general, it is desirable to minimize the concentration of chelating agent.
- Preferred concentrations are in the range of from about O.OlmM to about lOO M.
- the most preferred concentrations are in the range of from about 0.05mM to about lOmM.
- Substrates and chromogens with which the present invention is useful include those which are used in the detection of peroxidases.
- Chromogens which are useful include those which are well known in the art such as o-phenylenediamine, 2,2'-azinodi (3-ethyl) benzthiazoline-6-sulphonic acid (ABTS), dianisidine, dicarboxidine, TMB, diaminobenzidine.
- Preferred chromogens include any 3,3',5,5'-tetraalkylbenzidine in which the alkyl groups each contain from 1 to 5 carbon atoms; particularly useful are 3,3',5,5'- tetramethylbenzidine and 3,3',5,5'-tetraet_ylbenzidine.
- Acid salts such as the hydrochlorides also are useful.
- the amount of chromogen present in the substrate solution can vary over a considerable range, depending upon the identity and concentration of the peroxidase enzyme whose activity is to be measured; in general, the concentration of chromogen can vary from about 0.1 to about 10 M, preferably from about 1 to about 3mM.
- the amount of peroxide present also may vary, depending upon the amount of chromogen present, ranging from about 1 to about 20mM, but preferably it is from about 1 to about 6mM. Any of the usual peroxides such as hydrogen peroxide, urea peroxide, or the like can be employed in the substrate solution.
- the working solution is prepared by mixing a first stock solution containing a chromogen and a chelating agent with a second stock solution comprising an aqueous buffer solution containing the substrate and a chelating agent.
- the chelating agents of the two solutions may be the same or may differ.
- the chromogen solution can also comprise stabilizing or solubilizing agents.
- the working solution is prepared by mixing a first stock solution comprising an aqueous solution containing 5 to 50% N-methyl pyrrolidone by volume, 0.5 to ImM EDTA and 1 to 10 M 3,3',5,5'-tetraalkylbenzidine or an acid salt thereof with a second stock solution comprising an aqueous buffer solution containing 0.5 to ImM EDTA and 4 to 40 mM peroxide, and water if necessary to achieve the desired concentration.
- a first stock solution comprising an aqueous solution containing 5 to 50% N-methyl pyrrolidone by volume, 0.5 to ImM EDTA and 1 to 10 M 3,3',5,5'-tetraalkylbenzidine or an acid salt thereof
- a second stock solution comprising an aqueous buffer solution containing 0.5 to ImM EDTA and 4 to 40 mM peroxide, and water if necessary to achieve the desired concentration.
- Stock solutions can be supplied in the form of a kit which contains in addition a supply of conventional stopping agent solution, antibody- or antigen-coated containers, and antigen or antibody standards, calibrators or controls.
- the determination of enzyme activity is carried out in the usual manner by incubating the substrate solution with the specimen containing the enzyme to develop a visible color.
- a conventional stopping agent such as, for example, an aqueous solution of water-soluble flouride, such as sodium fluoride, at pH from about 3 to about 6; or acids such as sulfuric acid, hydrochloric acid, etc.
- a soluble fluoride is preferred because it provides a stable blue color.
- the present invention can be employed with any of the usual enzyme immunoassay procedures, either homogeneous or heterogeneous assays, and either single- or double-antibody assays, and including enzyme linked immunosorbent assays, immunoenzymometric assays and immunoperoxidase assays.
- Aqueous substrate solutions were prepared with the following compositions:
- the solutions were stored in glass at 4°C.
- Working substrate solutions with and without EDTA were prepared by combining one part of the respective TMB solution with 4 parts of the respective peroxide/acetate stock solution.
- the working solutions were stored in clear glass bottles at room temperature or at 4° to 6°C.
- 200 ⁇ L (microliters) of the solution were acidified with 50 ⁇ l l.ON H ⁇ SO, and the absorbance at 450 nm was measured in a spectrophotometer using water as a blank standard. The results are recorded in Table 1.
- the working substrate solution which contained EDTA was very stable for several days at 4 to 6°C and at room temperature. Without EDTA the nonenzymatic oxidation was so rapid that after a few hours the solution was no longer usable. The drop in absorbance at 7 days is probably due to the decomposition of the colored product occurring at a faster rate than it is formed.
- the effect of EDTA on enzyme activity was determined by running a horseradish peroxidase assay and varying the amount of horseradish peroxidase (lng/ml). 400 ⁇ l of the working solution of Example I, with and without EDTA, were added. The reaction was stopped after 10 minutes with 1 ml of 1 M HdonS0. and the absorbances at 450 nm were determined as before.
- Enzyme immunoassays were performed using the EDTA stabilized TMB/peroxide system for quantitation of carcinoembryonic antigen (CEA).
- CEA standards were prepared containing 0, 2, 5, 10 and 25 ngm/ml of CEA in serum respectively. 100 ⁇ l of each standard were added along with 100 ⁇ l of 50 nM acetate pH 5.3 buffer to separate IgG (anti-CEA) coated microtiter wells. The assays were incubated for 2.0 hours at 37°C. Each well was washed three times with water. A conjugate was formed by covalently linking A'-CEA IgG to enzyme horseradish peroxidase (HRP) diluted in buffer with protein stabilizer.
- HRP horseradish peroxidase
- dipicolinic acid prevented rapid non-enzymatic oxidation of the solution.
- Dipicolinic acid on the other hand, increased non-enzymatic oxidation relative to the control and would not be suitable for use as a stabilizer.
- HBsAg Hepatitis B surface antigen
- TMB/Peroxide substrate system prepared with and without varying chelating agents.
- Controls were prepared using HBsAg diluted in buffer with 1% bovine serum albumin as a positive and human serum as a negative. 200 ⁇ l of control were added to anti-BHsAg coated microtiter wells. 200 ⁇ l of water was used for the blank. The wells were incubated for 2 hours at 37°C and then washed three times with water.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI863968A FI863968A0 (fi) | 1985-02-11 | 1986-10-01 | Stabiliserade enzymsubstratloesningar. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US700,216 | 1976-06-28 | ||
US70021685A | 1985-02-11 | 1985-02-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1986004610A1 true WO1986004610A1 (fr) | 1986-08-14 |
Family
ID=24812635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1986/000229 WO1986004610A1 (fr) | 1985-02-11 | 1986-02-04 | Solutions enzymatiques stabilisees comprenant un substrat |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0213156A1 (fr) |
JP (1) | JPS62502653A (fr) |
FI (1) | FI863968A0 (fr) |
WO (1) | WO1986004610A1 (fr) |
ZA (1) | ZA86983B (fr) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0271713A2 (fr) * | 1986-12-15 | 1988-06-22 | Savyon Diagnostics Ltd. | Procédé de préparation de solutions aqueuses contenant des matières chromogènes |
WO1990002339A1 (fr) * | 1988-08-16 | 1990-03-08 | Cetus Corporation | Solutions temoins stables pour la detection d'une activite peroxydique |
EP0415471A2 (fr) * | 1989-08-31 | 1991-03-06 | INSTRUMENTATION LABORATORY S.p.A. | Réactif de Trinder stabilisé |
EP0488168A1 (fr) * | 1990-11-28 | 1992-06-03 | BEHRINGWERKE Aktiengesellschaft | Solution de lavage pour des méthodes immunométriques en phase solide, où il entre de constructeur de complexe d'ions métalliques et son application |
EP0491936A1 (fr) * | 1990-07-16 | 1992-07-01 | Diagnostic Markers Inc | Detection tres rapide des infections d'origine fongique. |
US5192657A (en) * | 1990-12-18 | 1993-03-09 | Ortho Diagnostic Systems, Inc. | Stabilized proteolytic solution and reagent kit |
US5206006A (en) * | 1989-08-31 | 1993-04-27 | Instrumentation Laboratory Spa | Stabilized trinder reagent |
US5332662A (en) * | 1992-07-31 | 1994-07-26 | Syntex (U.S.A.) Inc. | Methods for determining peroxidatively active substances |
US5532138A (en) * | 1990-04-26 | 1996-07-02 | Behringwerke Ag | Method and kits for determining peroxidatively active catalysts |
US5627075A (en) * | 1993-06-21 | 1997-05-06 | Boehringer Mannheim Corporation | Stable diagnostic reagent |
DE19544150A1 (de) * | 1995-11-16 | 1997-05-22 | Seramun Diagnostica Gmbh | Stabile 3,3',5,5'-Tetramethylbenzidin-Lösungen |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH073422B2 (ja) * | 1985-09-13 | 1995-01-18 | 富士レビオ株式会社 | 酵素免疫測定法用緩衝剤 |
JP7232475B2 (ja) * | 2020-12-28 | 2023-03-03 | ヤマサ醤油株式会社 | ロイコ型色原体の安定化方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4188465A (en) * | 1976-03-25 | 1980-02-12 | Boehringer Mannheim Gmbh | Stabilized urease composition |
JPS5534001A (en) * | 1978-08-28 | 1980-03-10 | Noda Sangyo Kagaku Kenkyusho | Stabilization of sarcosine oxidase |
US4282316A (en) * | 1979-09-11 | 1981-08-04 | Modrovich Ivan Endre | Stabilized enzymic solutions for determining urea |
EP0043550A1 (fr) * | 1980-07-04 | 1982-01-13 | BEHRINGWERKE Aktiengesellschaft | Agent pour la détection de substances à activité peroxidative et application de polyvinylméthylacylamide dans un tel agent |
US4331761A (en) * | 1976-09-24 | 1982-05-25 | Akzona Incorporated | Stabilization of peroxidase |
JPS57138389A (en) * | 1981-02-17 | 1982-08-26 | Toyobo Co Ltd | Stable urease composition |
DE3124590A1 (de) * | 1981-06-23 | 1983-01-27 | Boehringer Mannheim Gmbh, 6800 Mannheim | Stabilisiertes reagenz zum nachweis von h(pfeil abwaerts)2(pfeil abwaerts)o(pfeil abwaerts)2(pfeil abwaerts) |
US4378429A (en) * | 1979-08-23 | 1983-03-29 | Modrovich Ivan Endre | Enzymatic method and stabilized solutions for determining total cholesterol in human serum |
JPS58162294A (ja) * | 1982-03-18 | 1983-09-26 | Toyobo Co Ltd | 固定化複合酵素組成物 |
-
1986
- 1986-02-04 EP EP86901252A patent/EP0213156A1/fr not_active Withdrawn
- 1986-02-04 WO PCT/US1986/000229 patent/WO1986004610A1/fr not_active Application Discontinuation
- 1986-02-04 JP JP61501091A patent/JPS62502653A/ja active Pending
- 1986-02-11 ZA ZA86983A patent/ZA86983B/xx unknown
- 1986-10-01 FI FI863968A patent/FI863968A0/fi not_active Application Discontinuation
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4188465A (en) * | 1976-03-25 | 1980-02-12 | Boehringer Mannheim Gmbh | Stabilized urease composition |
US4331761A (en) * | 1976-09-24 | 1982-05-25 | Akzona Incorporated | Stabilization of peroxidase |
JPS5534001A (en) * | 1978-08-28 | 1980-03-10 | Noda Sangyo Kagaku Kenkyusho | Stabilization of sarcosine oxidase |
US4378429A (en) * | 1979-08-23 | 1983-03-29 | Modrovich Ivan Endre | Enzymatic method and stabilized solutions for determining total cholesterol in human serum |
US4282316A (en) * | 1979-09-11 | 1981-08-04 | Modrovich Ivan Endre | Stabilized enzymic solutions for determining urea |
EP0043550A1 (fr) * | 1980-07-04 | 1982-01-13 | BEHRINGWERKE Aktiengesellschaft | Agent pour la détection de substances à activité peroxidative et application de polyvinylméthylacylamide dans un tel agent |
JPS57138389A (en) * | 1981-02-17 | 1982-08-26 | Toyobo Co Ltd | Stable urease composition |
DE3124590A1 (de) * | 1981-06-23 | 1983-01-27 | Boehringer Mannheim Gmbh, 6800 Mannheim | Stabilisiertes reagenz zum nachweis von h(pfeil abwaerts)2(pfeil abwaerts)o(pfeil abwaerts)2(pfeil abwaerts) |
JPS58162294A (ja) * | 1982-03-18 | 1983-09-26 | Toyobo Co Ltd | 固定化複合酵素組成物 |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0271713A2 (fr) * | 1986-12-15 | 1988-06-22 | Savyon Diagnostics Ltd. | Procédé de préparation de solutions aqueuses contenant des matières chromogènes |
EP0271713A3 (fr) * | 1986-12-15 | 1989-07-12 | Savyon Diagnostics Ltd. | Procédé de préparation de solutions aqueuses contenant des matières chromogènes |
WO1990002339A1 (fr) * | 1988-08-16 | 1990-03-08 | Cetus Corporation | Solutions temoins stables pour la detection d'une activite peroxydique |
EP0415471A2 (fr) * | 1989-08-31 | 1991-03-06 | INSTRUMENTATION LABORATORY S.p.A. | Réactif de Trinder stabilisé |
EP0415471A3 (en) * | 1989-08-31 | 1991-05-29 | Instrumentation Laboratory S.P.A. | Stabilized trinder reagent |
US5108733A (en) * | 1989-08-31 | 1992-04-28 | Instrumentation Laboratory S.P.A. | Stabilized trinder reagent |
US5206006A (en) * | 1989-08-31 | 1993-04-27 | Instrumentation Laboratory Spa | Stabilized trinder reagent |
US5532138A (en) * | 1990-04-26 | 1996-07-02 | Behringwerke Ag | Method and kits for determining peroxidatively active catalysts |
EP0491936A4 (en) * | 1990-07-16 | 1992-08-26 | Diagnostic Markers, Inc. | Very rapid detection of fungal infections |
EP0491936A1 (fr) * | 1990-07-16 | 1992-07-01 | Diagnostic Markers Inc | Detection tres rapide des infections d'origine fongique. |
US5180664A (en) * | 1990-11-28 | 1993-01-19 | Behringwerke Aktiengesellschaft | Washing solution, which contains a complexing agent for metal ions, for a solid-phase immunometric method, and the use thereof |
AU653965B2 (en) * | 1990-11-28 | 1994-10-20 | Dade Behring Marburg Gmbh | A washing solution, which contains a complexing agent for metal ions, for a solid-phase immunometric method, and the use thereof |
EP0488168A1 (fr) * | 1990-11-28 | 1992-06-03 | BEHRINGWERKE Aktiengesellschaft | Solution de lavage pour des méthodes immunométriques en phase solide, où il entre de constructeur de complexe d'ions métalliques et son application |
US5192657A (en) * | 1990-12-18 | 1993-03-09 | Ortho Diagnostic Systems, Inc. | Stabilized proteolytic solution and reagent kit |
US5332662A (en) * | 1992-07-31 | 1994-07-26 | Syntex (U.S.A.) Inc. | Methods for determining peroxidatively active substances |
US5445944A (en) * | 1992-07-31 | 1995-08-29 | Syntex (U.S.A.) Inc. | Methods for determining peroxidately active substances |
US5627075A (en) * | 1993-06-21 | 1997-05-06 | Boehringer Mannheim Corporation | Stable diagnostic reagent |
DE19544150A1 (de) * | 1995-11-16 | 1997-05-22 | Seramun Diagnostica Gmbh | Stabile 3,3',5,5'-Tetramethylbenzidin-Lösungen |
DE19544150C2 (de) * | 1995-11-16 | 2002-06-13 | Seramun Diagnostica Gmbh | Stabile 3,3',5,5'-Tetramethylbenzidin-Lösungen |
Also Published As
Publication number | Publication date |
---|---|
JPS62502653A (ja) | 1987-10-15 |
FI863968L (fi) | 1986-10-01 |
ZA86983B (en) | 1986-09-24 |
EP0213156A1 (fr) | 1987-03-11 |
FI863968A0 (fi) | 1986-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dorsey et al. | A heated biuret-Folin protein assay which gives equal absorbance with different proteins | |
Hill et al. | Protein determination using bicinchoninic acid in the presence of sulfhydryl reagents | |
JPH0577399B2 (fr) | ||
US4521511A (en) | Catalyzed colorimetric and fluorometric substrates for peroxidase enzyme determinations | |
WO1986004610A1 (fr) | Solutions enzymatiques stabilisees comprenant un substrat | |
US5043266A (en) | Ortho- and para-imidazolyl and benzimidazolyl substituted phenol as enhancers for diagnostic chemiluminescent assays | |
NO165202B (no) | Askorbat-resistent bredomraadet glucoseproeveblanding. | |
US4596770A (en) | Assay of peroxidase enzyme activity | |
JPS6134799B2 (fr) | ||
Paz et al. | The amplefied detection of free and bound methoxatin (PQQ) with nitroblue tetrazolium redox reactions: Insights into the PQQ-locus | |
EP0490286B1 (fr) | Composition enzymatique pour l'essai d'éthanol | |
US4849342A (en) | Method for carrying out enzyme assays | |
EP0206316B1 (fr) | Méthode et composition d'essai pour la détermination du peroxyde d'hydrogène | |
KR100312056B1 (ko) | 아스코르브산의정량방법및정량용시약 | |
US4834918A (en) | Process and reagent for increasing the quantum yield in chemiluminescent reactions | |
US5266472A (en) | Stabilization of the enzyme urate oxidase in liquid form | |
JP3289280B2 (ja) | 基質液の安定化法及び基質液 | |
CA1339797C (fr) | Methode pour detecter des composes thioles dans un echantillon de fluide | |
JPH07108237B2 (ja) | ペルオキシダ−ゼ活性測定用薬剤およびその製法 | |
JPH04504467A (ja) | アルブミン―テトラゾリウム相互作用を使用するアッセイ | |
US4894472A (en) | Dicyanoethylaryl derivatives and process for their preparation | |
Kuan et al. | An alternative method for the determination of uric acid in serum | |
US4722894A (en) | Method for the determination of ceruloplasmin activity | |
AU595993B2 (en) | Dicyanoethylaryl derivatives and process for their preparation | |
US5166049A (en) | Measurement of diaphorase activity and reagent therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): BR FI JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 863968 Country of ref document: FI |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1986901252 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1986901252 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1986901252 Country of ref document: EP |